Cellectar Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)

9 Months Ended

Sep. 30, 2014

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

The following table summarizes information with regard to outstanding warrants to purchase common stock as of September 30, 2014.

	Number of Shares
	Issuable Upon
	Exercise of
	Outstanding		Exercise
Offering	Warrants		Price			Expiration Date

August 2014 Public Offering		5,040,011	$	4.68		August 20, 2019
February 2013 Public Offering (1)		550,000		3.75		February 20, 2018
February 2013 Public Offering – Placement Agents		38,496		12.50		February 4, 2018
November 2012 Private Placement		50,000		25.00		November 2, 2017
June 2012 Public Offering		149,069		25.00		June 13, 2017
December 2011 Underwritten Offering		462,411		12.00		December 6, 2016
April 2011 Private Placement		302,922		15.00		March 31, 2016
Legacy warrants (1)		1,365		3.75		July 27, 2015
Legacy warrants		5,252		321.30		July 27, 2015
Legacy warrants		4,570		1,989.00	- 2019.60	December 31, 2015
Total		6,604,096

(1)

The exercise prices of these warrants are subject to adjustment for “down-rounds” and the warrants have been accounted for as a derivative instrument as described in Note 2.

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details